Clik here to view.
Study Finds Strong Genetic Risk Factor for Kidney Disease
Discovery opens up possibilities for new potential therapeutic target for the disease and related renal dysfunctionSINGAPORE, Jul 13, 2016 - (ACN Newswire) - An international research collaboration has...
View ArticleClik here to view.
Singapore Scientists Discover New Pathways Leading to Cancer Progression
SINGAPORE, Jul 18, 2016 - (ACN Newswire) - Scientists from A*STAR's Genome Institute of Singapore (GIS) and the Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
View ArticleClik here to view.
A*STAR and MSD Establish a New Research Collaboration to Advance Peptide...
Peptide therapeutics will open up new opportunities to address unmet medical needsSINGAPORE, Jul 19, 2016 - (ACN Newswire) - Singapore's Agency for Science, Technology and Research (A*STAR) and MSD...
View ArticleClik here to view.
Singapore-based Luye Medical Group Signs MOU with China's City of Chongqing...
- Luye to invest RMB 2 billion (about S$400 million) to develop tertiary general hospitals and specialty centres in Chongqing- MOU will allow Luye to introduce knowledge and expertise from Singapore,...
View ArticleClik here to view.
Azelis announces Strategic Appointments
SINGAPORE, Jul 26, 2016 - (ACN Newswire) - Azelis, a leading global speciality chemicals distributor headquartered in Luxembourg, announces strategic organisational changes, including Asia, and a new...
View ArticleClik here to view.
Singapore Scientists Grow Mini Human Brains
Mini midbrains provide next generation platforms to investigate human brain biology, diseases and therapeuticsSINGAPORE, Jul 29, 2016 - (ACN Newswire) - Scientists in Singapore have made a big leap on...
View ArticleClik here to view.
Shanghai Pharmaceuticals Released 2016 Interim Results
Manufacturing and Retail Drove Business Growth; Implement Intensive Strategies for InnovationHONG KONG, Aug 25, 2016 - (ACN Newswire) - Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai...
View ArticleClik here to view.
Singapore Scientists Develop DNA-altering Technology to Tackle Diseases
The iCas protein (stained in red) created by Singapore scientists is shown moving into the cells' nuclei to make changes to the DNA (stained in blue). The pink region indicates that iCas is positioned...
View ArticleClik here to view.
New Silkroutes Group to Expand into Healthcare in Asia with Acquisition of...
Target company has expertise to manage hospitals; runs the largest employee healthcare benefits programme in Southeast AsiaSINGAPORE, Sep 15, 2016 - (ACN Newswire) - New Silkroutes Group Limited ("NSG"...
View ArticleClik here to view.
New Silkroutes Group in Joint Venture to Offer Private Equity Funds in Asia...
Mr Terence Ong Sea Eng, a former senior UOB banker, will head New Silkroutes Asset Management. - New Silkroutes Group has 30% stake in joint venture called New Silkroutes Asset Management, which will...
View ArticleClik here to view.
Shanghai Pharmaceuticals Released 2016 Q3 Results
Results Achieved Steady Growth with Extension and Expansion as Driving EngineHONG KONG, Oct 27, 2016 - (ACN Newswire) - Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the...
View ArticleClik here to view.
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage...
Paris, France and Cambridge, Massachusetts, USA, Nov 14, 2016 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches...
View ArticleClik here to view.
Scientists Successfully Create Blood from Skin Cells
Making blood from skin cells through direct reprogramming. (Image source: A*STAR's Genome Institute of Singapore)Development could pave way for improved therapeutics for patients with immune...
View ArticleClik here to view.
AugmentCare Appoints Privity as Advisor in its Early Stage Funding
DUBAI, UAE, Nov 28, 2016 - (ACN Newswire) - AugmentCare, an integrated digital healthcare platform focused on emerging markets, has announced the appointment of Privity FZ LLE, an independent...
View ArticleClik here to view.
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3
- Seven clinical trials across the world- More than 2/3 of STS patients recruited in the "act.in.sarc" Phase II/III trial- Phase I/II prostate cancer trial now recruiting in the U.S.Paris, France and...
View ArticleClik here to view.
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal...
Milestone in Stepping toward a Leading Global Pharmaceutical EnterpriseHONG KONG, Dec 1, 2016 - (ACN Newswire) - Luye Pharma Group Ltd. (2186.HK) is pleased to announce the completion of its...
View ArticleClik here to view.
Mr. Abraham Chan, Founder, Chairman, CEO and Executive Director of PuraPharm...
Mr. Abraham Chan, Founder, Chairman, Chief Executive Officer and Executive Director of PuraPharm (right), receives the "Directors of The Year Awards 2016" from HKIoD. HONG KONG, Dec 7, 2016 - (ACN...
View ArticleClik here to view.
NovogeneAIT Singapore and the Genome Institute of Singapore Forge...
Beijing and Singapore, Dec 8, 2016 - (ACN Newswire) - Novogene, a leading commercial provider of genomic services and solutions with cutting edge next-generation sequencing and bioinformatics...
View ArticleClik here to view.
Nanobiotix Reports Positive Phase I/II Preliminary Data on Feasibility and...
- Good safety and feasibility of the treatment at 10% dose level- Third indication in global development confirming transferability across different cancersParis, France and Cambridge, Massachusetts,...
View ArticleClik here to view.
Tongfang Kontafarma Announces Proposed Acquisition of 29% Stake in Korean...
Binex's bio-manufacturing facility in Songdo, Incheon, KoreaBinex's bio-manufacturing facility in Osong, KoreaBinex's 5,000-liter cell cultivation line at Osong facilityTo join hands with leading...
View Article